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The ability to correlate the production of specialized metabolites
to the genetic capacity of the organism that produces such
molecules has become an invaluable tool in aiding the discovery
of biotechnologically applicable molecules. Here, we accomplish
this task by matching molecular families with gene cluster families,
making these correlations to 60 microbes at one time instead of
connecting one molecule to one organism at a time, such as how it
is traditionally done. We can correlate these families through the
use of nanospray desorption electrospray ionization MS/MS, an
ambient pressure MS technique, in conjunction with MS/MS net-
working and peptidogenomics. We matched the molecular fami-
lies of peptide natural products produced by 42 bacilli and 18
pseudomonads through the generation of amino acid sequence
tags from MS/MS data of specific clusters found in the MS/MS
network. These sequence tags were then linked to biosynthetic
gene clusters in publicly accessible genomes, providing us with
the ability to link particular molecules with the genes that pro-
duced them. As an example of its use, this approach was applied
to two unsequenced Pseudoalteromonas species, leading to the
discovery of the gene cluster for a molecular family, the bromoal-
terochromides, in the previously sequenced strain P. piscicida JCM
20779T. The approach itself is not limited to 60 related strains,
because spectral networking can be readily adopted to look at
molecular family–gene cluster families of hundreds or more di-
verse organisms in one single MS/MS network.
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Tens of thousands of sequenced microbial genomes or roughdrafts of genomes are available at this time, and this number
is predicted to grow into the millions over the next decades. This
wealth of sequence data has the potential to be used for the
discovery of small bioactive molecules through genome mining
(1–6). Genome mining is a process in which small molecules are
discovered by predicting what compound will be genetically
encoded based on the sequences of biosynthetic gene clusters.
However, the process of mining genetically encoded small mol-
ecules is not keeping pace with the rate by which genome se-
quences are being obtained. In general, genome mining is still
done one gene cluster at a time and requires many person-years of
effort to annotate a single molecule. The time and significant ex-
pertise that current genome mining requires also make genome
mining very expensive. In light of this extensive effort and cost,
alternative approaches to genome mining and annotating spe-
cialized metabolites must be developed that not only take advan-
tage of the sequenced resources available and make it efficient to
perform genomemining on amore global scale but also enable the
molecular analysis of unsequenced organisms. Such methods will
then significantly reduce the cost of genome mining by increasing
the speed with which molecules are connected to candidate
genes and using resources already available. Here, we put for-
ward such an MS-based strategy that enables the genome mining
of small-molecule families from unsequenced organisms. This
strategy uses partial de novo structures inferred from nanospray
desorption electrospray ionization (nanoDESI)-based MS/MS
networking to connect to structures predicted from genomic
resources available in sequence repositories (2, 7). The MS/MS
network-based genome mining approach presented in this paper
takes a more global approach than is currently the norm. This
paper builds on many advances that have happened over the past
decade. First, an enormous amount of microbial sequencing
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data has been deposited in public databases and is waiting to
be mined (8–10). Second, our understanding of biosynthetic
pathways and the function of specific enzymes found in gene
clusters—especially for complex peptides made by nonribosomal
peptide synthetases (NRPSs)—has dramatically increased (11–
19). Third, the last decade has seen very significant advances in MS
with respect to ion sources and the sensitivity of the instruments
themselves (20–27). Ambient ionization methods combined with
significant improvements in sensitivity and mass accuracy of MS
instrumentation now enable the detection of intact molecules
directly from surfaces (7, 28–40). Using the ambient method
nanoDESI, the molecular characterization of microbial colonies
directly from agar surfaces without any prior sample preparation
has become possible (7).
In this study, nanoDESI is used to observe detectable metab-
olites, where we focused on nonribosomally synthesized pep-
tides, from unsequenced bacterial strains as well as representa-
tive sequenced Pseudomonas and Bacillus strains (Table S1).
These metabolites were subsequently subjected to MS/MS net-
working to first generate a molecular network representing the
detectable metabolites that are then related to one another
based on similarity of their fragmentation spectra, which is dic-
tated by their molecular structure (7). MS/MS networking was
then used to generate de novo peptide sequences from non-
ribosomally synthesized peptides as well as their respective mo-
lecular families (MFs). MFs are defined in this paper as a series
of related molecules based on their fragmentation behavior that
translates to structural similarity. MS-based genome mining us-
ing genomes in sequences repositories from related organisms
was then used to connect these MFs to their gene cluster families
(GCFs) (2, 7). GCFs are defined as gene clusters that exhibit
similar gene cluster organization with a high degree of sequence
similarity, where the A-domain specificity is minimally altered. We
targeted the well-studied family of molecules, the nonribosomal
peptide systems, with our MS/MS network-based genome mining
strategy to show that mass spectrometric signatures can be used to
group families of molecules from multiple organisms. Grouping
these MFs can, in turn, can be used to find candidate biosynthetic
gene clusters found in sequence repositories that could be re-
sponsible for the biosynthesis of such specialized metabolites at
a more global scale. For a detailed description on how biology
creates peptides without a ribosome, one should consult several
detailed reviews from the literature (18, 19). In short, NRPS-
derived peptides are produced by protein machineries that build
the peptides from a collection of more than 500 different amino
acid building blocks. Genome-based predictions of peptide cores
created by NRPS assemblies have now been automated and in-
tegrated into informatic tools, where a sequence is uploaded and
predictions are generated (41–45). In our opinion, NRPS-derived
molecules are the most readily achievable goals with respect to
genomemining because of the availability of extensive biosynthetic
studies in the last decades. It is, however, expected that, through
creative adaptation of the approach or related approaches, addi-
tional small-molecule classes, such as isoprenoids, polyketides,
oligosaccharides, glycolipids, lipids, and other natural products, can
be mined as well.
To accomplish genome mining of unsequenced organisms, we
used sequencing information from publicly available databases
as well as the predictive power of NRPS A domains (encoded
by NRPS genes in the sequenced genomes of related taxa) to
link the MS/MS peptide signatures of compounds produced to
candidate biosynthetic gene clusters. This technique allowed
us to correlate MFs [e.g., surfactin/lichenysin and viscosin/
white line-inducing principle (WLIP)/massetolide] from 60
strains of bacilli and pseudomonads to their respective GCFs
(46–49). We then applied this same methodology to assign the
gene cluster of the membrane-disrupting antimicrobial agent, the
bromoalterochromides (50–52), from a Panamanian octocoral-
associated Pseudoalteromonas species.
Results and Discussion
MS/MS Network-Guided Genome Mining. Matching of MFs with
GCFs of unsequenced microbes through association with se-
quenced genomes was accomplished by a four-step process
(outlined in Fig. 1A). In step 1 (Fig. 1A), fragmentation data for
the molecules produced by these microbes were obtained for
analysis by molecular MS/MS networking, effectively creating
a searchable molecular network for these organisms. For this
purpose, we chose nanoDESI MS as the ionization method.
NanoDESI, through a real-time liquid extraction, enables ioni-
zation of molecules directly from colonies grown on agar surfa-
ces in Petri dishes without any sample preparation, but other MS
techniques, such as liquid chromatography MS/MS or direct in-
fusion MS/MS, could also have been used (7). Because our
nanoDESI is interfaced with an ion trap, it was possible to
directly fragment all of the ions that were detected to obtain
MS/MS spectra. We subjected 60 different strains of bacteria to
nanoDESI analysis: there were 42 bacilli and 18 pseudomonads,
and their resulting MS/MS spectra were networked and visual-
ized with Cytoscape (Fig. 1 A, step 2, and B) (7, 53–55). Such
organization into networks enables the relationships between
spectrally identical and related molecules to be mapped based on
the spectral similarity of their MS/MS signatures. An MS/MS
cluster, where many nodes are connected by edges, indicates that
many related molecules were observed, whereas an MS/MS
cluster with few nodes may be a unique set of molecules with few
alternative forms, which results in unique spectra. Furthermore,
MS/MS networking enables the visualization of groups possess-
ing unique spectral signatures that indicate that the molecules
are distinct from the other molecules in a given dataset.
Both the bacilli and pseudomonad nanoDESI MS/MS data
were combined into one MS/MS network to create a searchable
molecular network. It was anticipated that very few of the MS/
MS signals that come from nonribosomal peptides would overlap
between the two organisms; there are no nonribosomal peptides
that have been described in the literature that are found in both
bacilli and pseudomonads, and no NRPS gene clusters between
these genera are related to one another (46–49). The merging
of the data also enables the removal of overlapping signals
that are not of interest, including any signals derived from the
growth medium, although individual networks for the bacilli and
pseudomonads could have been created. Combining the data
from all organisms assists in the peptidogenomics-based genome
mining, because only one MS/MS node needs to be matched to
its corresponding genome. This genome can then be related to
the surrounding nodes in the MS/MS cluster, and therefore, not
every MS/MS spectrum has to be individually correlated to
candidate gene clusters, even when it originates from different
organisms. This effort required to correctly correlate a GCF–MF
pair is additive and only required one time. Any newer molecules
that are added to this network and cluster within a particular MF
can then have the previously linked GCF–MF pair related to it.
Finally, the vast majority of nonribosomal peptides isolated from
these genera contains proteinogenic amino acids, thus simplify-
ing the peptidogenomic analysis. Although there are nonpeptidic
molecules that are observed in the MS/MS network, such as the
rhamnolipids and quinolones (56) (Fig. S1), the goal of the
analysis of these 60 strains was to provide a proof of principle to
correlate nonribosomal peptides to their candidate gene clusters.
Although we only used 42 bacilli and 18 pseudomonads, this
technique can be scaled to hundreds, thousands, or even tens of
thousands of organisms, sequenced or unsequenced, and still
requires only one MS/MS node to be matched to its corre-
sponding genome. Combining the MS/MS data from the bacilli
and the pseudomonads resulted in about 22% (972/4,311 nodes)
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overlap in signals. Likely sources for these common molecules
are primary metabolism, the nanoDESI solvent, the growth
medium, and molecules that fragment poorly. The majority of
spectra (78%) is unique to either the bacilli or the pseudomo-
nads (Fig. 1B). There are 121 MS/MS clusters that contain three
or more nodes of unique fragmentation patterns; these MS/MS
clusters visualize individual MFs.
After the MS/MS network had been generated in step 2 (Fig.
1A), we examined the raw MS/MS data looking for mass shifts
between adjacent ions corresponding to the mass of an amino
acid, thereby creating a sequence tag that would indicate that
a particular MS/MS cluster is peptidic in nature (Table S2). The
peptidic clusters were then subjected to peptidogenomic analysis
(Fig. 1A, step 3). We limited this search space to only protei-
nogenic amino acids (with and without an N-methyl group),
because manual annotation of spectra with the more than 500
possible unique amino acids that can be incorporated into non-
ribosomally produced peptides is a nearly impossible task, es-
pecially with low-resolution MS/MS data. In the future, specific
algorithms can be developed that will overcome this limitation,
especially in conjunction with high-resolution MS/MS data. In-
stead of carrying out peptidogenomics analysis on a single or-
ganism as previously described, the peptide backbones of all of
the NRPS gene clusters from all available genome sequences of
bacilli and pseudomonads in the public databases were predicted
using a batch form of antibiotics and Secondary Metabolite
Analysis SHell (antiSMASH) as well as curation using other A-
domain prediction tools (4, 16, 43, 44, 57) (Tables S2 and S3). By
combining amino acid MS/MS signatures with the predicted
amino acid specificity of NRPS A domains, we obtained candi-
date matches of MS/MS signatures to particular GCFs. At this
stage, the iterative process of examining and matching MS data
to the gene clusters, which is done in peptidogenomics analysis,
was carried out, because this information is needed to correlate
MFs and GCFs and can then be related to surrounding nodes
within the MS/MS cluster (2). To improve our confidence in the
peptidogenomics analysis, we looked for several correlations. (i)
Can we find additional amino acids that correlate to the A-domain
specificity predictions that were missed when generating the initial
sequence tag from the MS/MS data? (ii) Does the biosynthetic
gene cluster contain tailoring domains in the NRPS or bio-



















Fig. 1. Process of MS/MS networking-guided genome mining of nonribosomal peptides produced by unsequenced organisms and the molecular network
generated from 42 bacillus and 18 pseudomonad strains. (A) Step 1: nanoDESI MS on live microbial colonies to determine molecular mass and obtain MS/MS
fragmentation data. Step 2: generation of molecular networks and visualization using Cytoscape. Step 3: peptide sequence tag generation from raw spectra
of MS/MS clusters and prediction of NRPS gene clusters (antiSMASH) from genomic data available in public databases. Step 4 (1): biosynthetic gene cluster
analysis to verify candidate molecules. Step 4 (2): if the putative matches are of high priority, proceed with full structure elucidation from MSn and NMR data.
(B) Molecular network of 42 bacilli (pink) and 18 pseudomonad (green) strains.















those amino acids be found in the MS/MS data? (iii) Did we
observe patterns of mass shifts in the parent ions, such as ±14 Da,
indicative of a different set of amino acid substitutions (e.g., Gly
vs. Ala), different methylations, or different fatty acid chain
lengths that are common to nonribosomal peptides? (iv) Does the
size of the molecule match up to the size of the gene cluster (e.g.,
an NRPS with 20 A domains is unlikely to encode for a molecule
that is ∼1,000 Da)? (v) Does the biosynthetic pathway match the
MF structural prediction? If these correlations all agree, then it is

















































Surfactin  biosynthetic gene cluster B.subtilis
* Glu Leu Leu LeuLeuAspValE EC C C C C C
B. amyloliquefaciens
* Glu Leu Leu LeuLeuAspValE EC C C C C C
B. atrophaeus
* Glu Leu Leu IleLeuAspValE EC C C C C C
B. licheniformis




































tag 113-113 of all available bacilli sequencing data.
Sequence origin
B. amyloliquefaciens CAU-B946, complete genome.
B. subtilis srfAA and srfAB genes for surfactin synthetase.
B. subtilis subsp. subtilis RO-NN-1, complete genome.
B. atrophaeus 1942, complete genome.
B. licheniformis BNP29, lichenysin A synthetase operon.
B. subtilis srfA-sfp surfactin synthetase.
B. licheniformis ATCC 14580, complete genome.
B. subtilis BSn5 chromosome, complete genome.
B. licheniformis, lichenysin biosynthesis operon.
B. subtilis subsp. subtilis, surfactin synthetase.
Fig. 2. Molecular network from bacilli and pseudonomads with the identification of the surfactin MF. (A) Surfactin MF (boxed and enlarged) originating
from the bacilli MS/MS clusters. (B) Random selection of nodes for raw MS/MS spectra analysis and sequence tag generation. (C ) Genome mining by
antiSMASH of all publicly available sequenced bacilli genomes. (D) Matching the generated sequence tags to all of the predicted NRPS gene clusters from
bacilli genomes. Starred domains are starter condensation domains.
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found. When the molecule or gene cluster is very important based
on biological prioritization, the GCF–MF correlation will need to
be confirmed by other means as described below. Below are more
detailed examples of how such GCF–MF correlations were
obtained for known compounds from bacilli and pseudomonads.
Nonribosomally Produced Peptides from Bacilli. Mapping the search-
able molecules through the creation of a molecular network from
60 organisms revealed a large cluster of 78 nodes representing
molecules with masses ranging from 1,002 to 1,116 Da found only
within the bacilli data (Fig. 2A). The data incorporated in the
nodes came from 23 different datasets (Table S4). Generation of
sequence tags using only proteinogenic amino acids revealed a 113
Da and a 113–113 Da pair of signatures characteristic of peptides
(Fig. 2B). For the purposes of this study, the longest consecutive
sequence tag was used to carry out peptidogenomics, because
longer tags are more likely to lead to correct identifications. Fu-
ture algorithms with high-resolution data will enable one to take
into account all of the tags that are generated, including those tags
with nonproteinogenic amino acids. For this MS/MS cluster,
a search tag of 113–113 Da, corresponding to Leu-Leu, Leu-Ile,
Ile-Leu, or Ile-Ile, was used to search all of the predicted NRPS
sequences obtained from the A-domain specificity predictions of
the publicly available sequences of bacilli and pseudomonads. This
113–113 Da sequence tag matched to sequence tags from B.
subtilis, B. amyloliquefaciens, B. atrophaeus, and B. licheniformis
but not predicted sequence tags from the pseudomonads. This
GCF included the B. subtilis surfactin and B. lichenformis lichen-
ysin synthetases. Comparing the gene cluster matches from the
bacilli revealed that all of the gene clusters had related A-domain
specificities and similar gene cluster organization, with over 80%
protein sequence similarity (Fig. 2D). This sequence tag and A-
domain specificities are in agreement with the known structures of
surfactin and lichenysin. At least 17 lichenysins and 53 surfactins
are described in the literature with different fatty acid lengths and
geometries as well as different amino acids in the backbone of the
molecule, because the promiscuity of many A domains leads to the
production of MFs. Thus, the surfactin/lichenysin family GCF was
identified. We had included some sequenced strains, such as B.
subtilis 3610, making it possible to verify from the fragmentation
data alone whether the MF contained surfactin. Indeed, the sur-
factin fragmentation data from B. subtilis 3610 is found in this
cluster (Fig. S2). Using this approach, four candidate GCF–MF
pairs were identified from bacilli (Fig. S1).
Nonribosomally Produced Peptides from Pseudomonads. Similar
results were obtained for the pseudomonads. For example,
a 17-node MS/MS cluster ranging from 1,133 to 1,193 Da con-
tained a tag of 87–113-87–113 Da corresponding to Ser-Leu-Ser-
Leu, Ser-Ile-Ser-Leu, Ser-Leu-Ser-Ile, Ser-Ile-Ser-Ile, and re-
verse sequences (Fig. S3). This sequence tag, from MS/MS data
obtained from unsequenced P. tolaasii, P. putida, and P. aur-
antiaca, matched to the predicted GCFs only from the pseudo-
monads and not the bacilli. The matches included the viscosin,
WLIP, and massetolide gene clusters. Therefore, both the gene
clusters and molecules that were identified from this GCF–MF
pair belong to the viscosin/WLIP and massetolide family of
molecules. We confirmed the viscosin cluster by adding MS/MS
data from P. putida RW10S2, a known WLIP producer (58).
Four candidate GCF–MF pairs were identified from the pseu-
domonads (Fig. S1). To date, despite the importance of the
strain in agriculture, P. tolaasii strains are not described to make
a molecule belonging to this MF. On closer inspection, however,
a GCF, with the correct gene and domain organization to the
viscosin MF, is found in the draft genomes of P. tolaasii PMS117,
2192, and 6264, consistent with our observations. Based on these
two proof-of-principle results, we applied this strategy of genome
mining using MFs to all MS/MS clusters with peptidic signatures.
This strategy revealed that 8 of 121 MS/MS signatures could be
correlated to GCFs (Fig. S1): the GCFs of iturin, surfactin/
lichenysin, kurstakin, bacitracin, viscosin, thanamycin, entolysin,
and amphisin were successfully paired with their respective MFs.
Dereplication and Validation of GCF–MF Correlations. When making
such correlations, there are at least four possible outcomes. First,
the gene cluster and MS data for a given molecule may match
perfectly with a known molecule–gene cluster pair already de-
scribed in the literature, which was the case for the bacilli and
pseudomonad examples (Fig. S1). Second, a known molecule is
successfully associated to a gene cluster or family of gene clus-
ters, where this pair had no prior example in the literature.
Third, a family of gene clusters may be associated with a known
molecule based on the MS, MS/MS, and GCF analysis. Fourth,
there is the possibility that, using the dereplication strategies that
we used here, a newly discovered gene cluster may match a newly
discovered molecule not previously associated with any molecule
already described in the literature. This outcome may indicate
either a new molecular entity or an incorrect match.
How can we validate any of these correlations? At this stage,
we cannot validate them unless additional confirmation is ac-
quired. There are many avenues to perform such verifications.
These avenues include matching the MS/MS data to MS/MS data
published in the literature, comparative in silico dereplication to
databases such as Norine, isolation and NMR analysis of the
molecule, creating KOs of the gene cluster, and (partially) se-
quencing the gene cluster to verify that it is, indeed, present
within the genome of the unsequenced organism. Because the
costs for validation are so significant, it is our opinion that these
approaches should only be performed when the molecules are of
great biological or chemical interest. However, if the effort re-
quired for verification of a single molecule takes place, this
verification can be extended to the entire GCF–MF correlation
and will never have to be carried out again. Furthermore, any
new data from molecules or organisms that are added to a net-
work that also clusters to an existing GCF–MF pair can have the
original verification extended to them. However, if such addi-
tional verification fails, then the GCF–MF association is in-
correct. Thus far, we have not encountered such a scenario with
our data. GCF–MF pairs that could not be verified by the lit-
erature or where no literature is found should only be considered
putative associations. Although the above analysis was not an
exhaustive search, the data provided sufficient evidence that the
methodology works and is providing the foundation for future
algorithmic development.
Associating GCFs with Biologically Interesting MFs from Unsequenced
Organisms. Having established the methodology of MS/MS-
guided genome mining of unsequenced organisms, we wanted
to show the use of the method to identify a gene cluster for
a molecule showing antimicrobial activity from unsequenced
organisms. Two Pseudoalteromonas species (strains OT59 and
04M1A) were isolated from the Panamanian octocorals Lep-
togorgia alba and Psammogorgia sp., respectively. Both of these
strains showed inhibitory activity against B. subtilis 3610 when
cocultured on agar. We used microbial MALDI imaging MS
(MALDI-IMS) to monitor the distribution of metabolites and
determine which of these metabolites are responsible for the
observed bioactivity (22). Subjecting a coculture of Pseudoalter-
omonas and B. subtilis 3610 to IMS revealed two MS signals, m/z
880 and 960, from strain 04M1A that sit at the zone of inhibition,
suggesting that these molecules may contribute to antibiotic
activity (Fig. 3A). We isolated these molecules by HPLC and
tested the fractions in a conventional disk diffusion assay
against B. subtilis 3610. This isolation revealed that a molecule
with mass of 921.191 Da (protonated vs. potassiated adduct at
m/z 960 Da) was a major contributor to the antibiotic activity.















Cytological profiling of both DNA and the cell membrane
suggested that the mechanism of action of the 921.191 Da
compound is similar to the mechanism of action of nisin, which
is an amphipathic cationic peptide that disrupts cytoplasmic
membranes and is distinct from other membrane active com-






























































































































































Fig. 3. IMS andMS/MS networking of the bromoalterochromide family and fluorescence microscopy of the 921.191 Da dibromoalterochromide and its effect on B.
subtilis 3610 cells. (A) MALDI-IMS showing bromoalterochromide production by PseudoalteromonasOT59 and 04M1A and its special correlation with B. subtilis 3610
inhibition. (B) Fluorescence micrographs of growing B. subtilis 3610 cells treated with DMSO, 2,4-dinitrophenol (DNP), or the 921.191 Da dibromoalterochromide.
Red stain is FM 4–64, a fluorescent membrane stain; green stain is Sytox Green, a DNA stain that is membrane-impermeable and shows increased fluorescence in
permeabilized cells. (C) Fluorescence micrographs of growing B. subtilis 3610 cells treated with DMSO, DNP, and two concentrations of nisin; the 921.191 Da
dibromoalterochromide is at or below the minimum inhibitory concentration. (D) MS/MS networking from nanoDESI MS of Pseudoalteromonas OT59 and 04M1A.
The monobromoalterochromide gives two major isotopes, whereas the dibromoalterochromide gives three major isotopes. At least one of these isotopes was
detected by MS/MS networking. (E) Node selection of predicted bromoalterochromide species (possibly present as protonated, sodiated, and potassiated adducts)
for raw MS/MS spectra analysis and sequence tag generation. Amino acid mass shifts of 113–114 Da correspond to a sequence tag of Ile-Asn or Leu-Asn.
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Subjecting colonies of Pseudoalteromonas OT59 and 04M1A
grown on agar to nanoDESI and MS/MS networking revealed
that the mass of 921.191 Da belonged to a cluster of related
molecules (Fig. 3D). Inspecting the MS/MS data from the
921.191 Da and surrounding nodes revealed that the molecules
were peptidic and had a sequence tag of Ile/Leu and Asn (Fig.
3E). A search in the AntiMarin database did not find a match for
the 921.191 ion, but there was a match to a related node. The
match was to a molecule with a mass of 843.280 Da named
bromoalterochromide A and A′, an unusual monobrominated
lipopeptide (Fig. 3E) (50, 51). To confirm that the 921.191 Da
compound isolated from both OT59 and 04M1A was, indeed,
a bromoalterochromide, the MS/MS spectra were further ex-
amined, and an NMR analysis of the purified compound was
performed (Table S5). These data were compared with the data
found by Kalinovskaya et al. (51). Both the NMR and MS/MS
analysis support the assignment of this molecule to the bro-
moalterochromide family. This finding highlights how MS/MS
networking tools can be used to dereplicate related molecules.
Our molecule was 77.911 Da larger than the bromoalter-
ochromide found in AntiMarin, suggesting that our molecule was
a doubly brominated bromoalterochromide. To find a candidate
GCF, every publicly available Pseudoalteromonas sp. genome was
mined for NRPS or NRPS/polyketide synthase (PKS) hybrid
gene clusters (which we had done with the bacilli and pseudo-
monads), and the A-domain specificities were examined until we
found a positive hit within P. piscicida JCM 20779T (52). The A-
domain and gene cluster analyses revealed that the gene cluster
from P. piscicida contained a halogenase, type II polyketide
synthase/type II fatty acid proteins, and NRPS modules that are
predicted to load Thr-Val-Asn-Asn-Ile/Leu (Table S6). This evi-
dence means we have found a putative GCF–MF pair.
Confirming the GCF–MF Pairing of the Bromoalterochromides from
Pseudoalteromonas. Several complementing approaches were
used to verify that this molecule was, indeed, a member of the
bromoalterochromide family of NRPS-derived molecules. If our
prediction of the GCF–MF pair was indeed correct, then the
sequenced organism P. piscicida JCM 20779T should also pro-
duce the bromoalterochromides, although this finding has not
been described in the literature. To confirm the production of
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Fig. 4. MS/MS networking of Pseudoalteromonas OT59 and 04M1A and piscicida JCM 20779T. (A) MS/MS cluster of bromoalterochromide (red, orange,
yellow, gray, and teal nodes are 04M1A, OT59, P. piscicida JCM 20779T, OT59/04M1A, and metabolites originating from all organisms, respectively). (B)
Bromoalterochromide gene cluster. Purple, ammonia lyase; orange, type II PKS/fatty acid synthase; red, NRPS; gray, transporters; green, thioesterase; pink,
halogenase; black, hypothetical proteins. (C) Proposed biosynthetic pathway with speculative double halogenation by ORF 238 after acyl chain elongation.















organism was obtained and subjected to nanoDESI. MS/MS data
generated from P. piscicida JCM 20779T were merged with the
MS/MS networking data from OT59 and 04M1A, revealing that
P. piscicida JCM 20779T does, indeed, produce compounds
that fall within the bromoalterochromide cluster. This result
suggests that the biosynthetic machinery is present in P. piscicida
JCM 20779T like in OT59 and 04M1A (Fig. 4). Interestingly,
P. piscicida JCM 20779T only produces the 843.280 Da mono-
bromoalterochromide and not the 921.191 Da dibromoalter-
ochromide, whereas OT59 and 04M1A produce both. These
results provide additional confirmation that the GCF–MF pair
has correctly been identified and that it is possible to connect
MFs from unsequenced organisms to GCFs in publicly available
sequencing data. Having candidate molecules and the gene
cluster in hand, it is now possible to evaluate if the molecule and
biosynthetic gene cluster match as well. The gene cluster con-
tains all of the biosynthetic components needed to produce the
bromoalterochromides and was identified bioinformatically (Fig.
4 and Table S6). The condensation and epimizerization domains
were subjected to phylogenetic analysis with starter C domains,
LCL and
DCL condensation domains, dual C/E domains, and
standalone E domains as described by Rausch et al. (59). Inter-
estingly, the epimerization domains from P. piscicida JCM
20779T do not clade tightly with the epimerization domains from
B. cereus, B. licheniformis, or B. subtilis, most likely because of
phylogenetic divergence of the organisms, which also inhabit
different ecological niches (Fig. S4). Still, the epimerization
domains are in the correct locations to encode for D-Thr, D-Val,
L-Asn, D-Asn, and D-Leu/Ile as previously described (50, 51).
The polyketide portion of the biosynthetic pathway is missing
the enoyl reductase, which one would predict based on the
structure of the molecule. Lastly, the pathway contains a flavin-
dependent halogenase. The only other candidate brominating
flavin-dependent halogenase described to date is found in the
jamaicamide pathway (60). Again, the gene cluster analysis
matches perfectly with the expected biosynthesis of the bro-
moalterochromides, supporting the notion that this molecule
family, including 921.191 Da, belongs to the bromoalter-
ochromide family. Finally, to further confirm this finding of the
bromoalterochromide GCF–MF pair, we set out to show that
similar biosynthetic genes exist in our strains. For this reason,
OT59 and 04M1A were subjected to partial genome sequencing
using Illumina sequencing, which revealed that the same NRPS
genes are present with 96% identity to the genes found in P.
piscicida JCM 20779T based on BLASTN sequence alignments
(Fig. S5). The extensive tasks, ranging from NMR analysis of the
purified bromoalterochromide to the gene cluster analysis and
partial sequencing of OT59 and 04M1A, were carried out to
verify, with complete certainty, that we had the correct molecule
as well as the correct GCF–MF pairing. All of this information
was dedicated to the analysis of the 921.191 Da dibromoalter-
ochromide, but it can now be extended to the various family
members of this molecule. Additionally, if any other data are
added to this network and cluster to this MF, the steps for veri-
fication of the molecule and GCF–MF pairing do not need to be
carried out again, thus increasing the speed and reducing the cost
of studying these molecules. Combined, these data show that MS/
MS networking peptidogenomics analysis enables the mapping of
observed MFs to already available sequenced genomes and that
it can lead to the discovery of previously unidentified GCFs,
which we showed for the 921.191 Da antimicrobial agent dibro-
moalterchromide from unsequenced Pseudoalteromonas species.
Conclusion
One of the major bottlenecks in genome mining is that it takes
a significant amount of time and money to connect a molecule to
its biosynthetic signature. Here, we have highlighted one example
of how we can increase the speed and reduce the cost of the
analysis of specialized metabolites from a large cohort of organ-
isms using sequence information already available in public
databases. We targeted NRPS systems with our MS/MS network-
based genome mining strategy to show that genome mining can
be accomplished for unsequenced organisms by borrowing an
already sequenced genome of a related organism. We expect,
however, that, through the creative adaptation of this approach,
additional small-molecule classes, such as isoprenoids, poly-
ketides, oligosaccharides, glycolipids, and lipids, can be mined as
well. Connecting the GCFs and MFs is additive, because it pro-
vides an approach to correlate molecules to genetic information
that, after linked in a manner that is analogous to annotations in
sequence repositories, can be extrapolated quickly to new sam-
ples, especially as more genome sequences become available.
This additivity saves time and effort, and so far, we have not yet
reached a limitation in terms of the number of samples that can
be compared. Such an approach (or related approaches) will
become the first step in the molecular characterization of unse-
quenced microbes, even in field-collected samples, especially as
mass spectrometers interfaced with ambient ionization are be-
coming cheaper and even portable (39, 40). Our approach could
serve nicely as a strain preselection strategy for therapeutic dis-
covery applications, and it is now beginning to be used in our
laboratories to mine metagenomics data rather than strictly full
genome sequencing data. With this approach, one can begin to
create GCF–MF associations for molecules analyzed directly
from environmental and personal microbial communities, such as
the ones found on our skin, our gut, soil, coral reefs, or plant
roots—something not commonly attempted with today’s genome
mining technologies—thereby avoiding the requirement of pro-
ducing viable cultures in the laboratory.
Materials and Methods
Bacilli, Pseudomonad, OT59, 04M1A, and P. piscicida JCM20779T Culture
Conditions. The 42 bacilli and 18 pseudomonads are listed in Table S1. All
strains were grown in LB broth (Fischer Scientific) overnight, shaken at 28 °C,
transferred to 1 L medium containing 4 g yeast extract (Sigma Aldrich), 10 g
malt extract (Sigma-Aldrich), 4 g dextrose (EMD), and 10 g agar (Sigma-
Aldrich) to make ISP2 agar, and incubated for 48 h at 30 °C. OT59, 04M1A, and
P. piscicida JCM 20779T were grown on 500 mL medium contained 9 g agar
(Sigma-Aldrich), 5 g potato starch (Sigma-Aldrich), 2 g yeast extract (Sigma-
Aldrich), 1 g peptone (Sigma-Aldrich), and 14 g aquarium salt (Aquatic Sys-
tems; Instant Ocean) to make M1 agar.
Sample Preparation for MALDI. After the strains were grown individually for
48 h on ISP2 agar, ∼1 μL cells was scraped directly from the live colony and
transferred to an microScout Plate 96 MALDI anchor plate. The cells were
then covered with 1 μL saturated matrix solution [35 mg/mL Universal MALDI
Matrix (1:1 mixture of 2-5-Dihydroxybenzoic acid (2,5-DHB) and α-cyano-4-
hydroxy-cinnamic acid; Sigma-Aldrich) in 78%/21%/1% (vol/vol) acetonitrile/
water/formic acid] until proper crystal formation. The MALDI plate was
inserted into an Autoflex Bruker Daltonics mass spectrometer, and data
were recorded in reflectron positive mode. Data analysis was carried out
using ClinProTools to generate heat maps to analyze chemical profiles of the
strains simultaneously.
Live Colony NanoDESI MS/MS Data Acquisition. Overnight cultures of bacilli
and pseudomonads were prepared as stated above. Four cultures (0.5 μL
each) were spotted on an ISP2 agar plate and grown for 48 h at 30 °C.
Colonies of OT59, 04M1A, and P. piscicida JCM20779T were grown as stated
above. NanoDESI was carried out as described by Watrous et al. (7) using
a solvent mixture of 65:35 acetonitrile:water with 0.05% formic acid for the
bacilli and pseudomonads and 50:50 MeOH:water with 1% formic acid for
the Pseudoalteromonas. Spray voltage was kept between 2.0 and 3.0 kV.
Data were collected using a data-dependent MS/MS method on a hybrid
6.4T LTQ-FT (Thermo Electron) mass spectrometer. In this method, an MS1
scan of 50–1,600m/z was followed by MS/MS of the four most intense ions (2
m/z isolation width, a normalized collision energy of 35%, and an activation
time of 30 ms), which were then added to an exclusion list, allowing for
another MS1 scan followed by MS/MS of the next four most intense ions.
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MS/MS Networking and Sequence Tagging. The MS/MS data of 42 bacilli, 18
pseudomonads, OT59, 04M1A, and P. piscicida JCM 20779T were clustered as
described by Pierce et al. (34). Algorithms assumed a precursor mass toler-
ance of 1.0 Da and a fragment mass tolerance of 0.3 Da with the cosine
threshold set at 0.7. Two plugins were used for aid with data visualization.
The FM3 layout was used to organize and align the nodes within the net-
work, and the HiderSlider plugin was used to hide or show nodes within the
network to determine whether the origin of the node was bacilli or pseu-
domonad. After clusters of specific molecules were located, individual nodes
were selected, and the MS/MS spectra were examined for sequence tags.
Peptidogenomics and Genome Mining. All available genome sequences for the
bacilli and pseudomonads were gathered from the National Center for
Biotechnology Information, US Department of Energy Joint Genome In-
stitute, and PseudoDB. Pseudoalteromonas spp. genomes used for pepti-
dogenomics and genome mining are described by Xie et al. (52). Targeted
nucleotide sequences were subject to antiSMASH, NP.searcher, NRPSpre-
dictor2, and PKS/NRPS analysis to determine the amino acid specificity of the
NRPS A domain (4, 16, 43, 44, 57). NRPS and NRPS/PKS hybrid gene clusters
were screened with the Ile/Leu-Asn sequence tag obtained from molecular
networking. After obtaining potential NRPS gene clusters, the protein
sequences were pulled out, and A-domain accuracy was examined by PKS/
NRPS analysis to eliminate NRPS genes that were unlikely to produce the
bromoalterochromides. For all remaining gene clusters, BLAST analysis was
performed on the NRPS-surrounding genes to determine their functions.
MALDI-IMS Screening of Pseudoalteromonas OT59 and 04M1A Against B.
subtilis 3610. B. subtilis 3610 was grown to an OD of 0.2–0.5 in M1 liquid
media, and 20 μL were spotted onto an M1 agar plate (described above) and
spread into a lawn using glass beads. The cultures were allowed to dry, at
which point 2 μL OT59 or 04M1A stock, frozen at an OD of 1.0 in 20%
glycerol in M1 liquid media, were spotted at the center of the plate. The
cultures were incubated at 30 °C in the dark for 48 h. The interactions of
OT59 with B. subtilis 3610 were prepared as stated above. These inter-
actions, as well as the corresponding controls, were excised out of the agar
and placed on a Bruker MSP 96 stainless steel target plate. A film of Uni-
versal MALDI Matrix (Sigma-Aldrich) was applied to the surface of the ex-
cised agar using a 53-μm sieve (Hogentogler & Co., Inc.). The target plate was
dried at 37 °C until the agar pieces had dried completely and adhered to the
target plate. The samples were subjected to MALDI-IMS using reflectron
positive mode on a Bruker Microflex with Compass 1.2 software suite con-
taining flexImaging 2.0, flexControl 3.0, and flexAnalysis 3.0.
Extraction and Isolation of the 921.191 Da Dibromoalterochromide. OT59 stock
(2 μL), frozen at an OD of 1.0–1.2, was inoculated onto M1 agar plates. The
colonies were grown for 48 h at 30 °C, at which point the colonies were
excised from the agar plate and extracted with methanol. The crude extract
was fractionated on a Sephadex LH-20 column (MeOH) at a flow rate of 1.5
mL/4 min, where the fractions were tested for bioactivity against B. subtilis
3610. Lawns of B. subtilis 3610 were prepared as stated above. The fractions
were dried down and resuspended in 10–100 μL methanol; 2–8 μL were
spotted onto a paper disk, allowed to dry, and then placed onto the newly
prepared lawn of B. subtilis 3610. The cultures were incubated in the dark at
30 °C for 48 h. Bioactive fractions were analyzed by MALDI for molecular
signature. Bioactive sephadex fractions containing the bromoalter-
ochromides were pooled together and finally purified by HPLC to obtain the
921.191 Da dibromoalterochromide. Purification was performed on an
Agilent 1260 HPLC equipped with a Discovery reverse-phase C18 5-μm, 180
A, 25-cm × 10-mm column (Supelco) using the water/acetonitrile gradient
listed below. Solvent A is HPLC-grade water (J. T. Baker) with 0.1% TFA
(Sigma-Aldrich), and solvent B is HPLC-grade acetonitrile (J. T. Baker) with
0.1% TFA. The gradient was run at a flow rate of 2 mL/min.
NMRMeasurements of the 921.191 Da Dibromoalterochromide. NMR data were
acquired at the University of California at San Diego Skaggs School of
Pharmacy and Pharmaceutical Sciences NMR Facility. Proton and 2D NMR of
the purified 921.191 Da dibromoalterochromide were measured on a 600
MHz NMR (Manex superconducting magnet, 14.1 T) fitted with a 1.7-mm
cryoprobe and Bruker Avance console and operated using Bruker
TopSpin software.
Fluorescence Microscopy. B. subtilis PY79 was grown in LB to an OD600 of
0.3, centrifuged, and resuspended in 1/10th of the volume; 14.25 μL con-
centrated cells were added to 1.7-mL microcentrifuge tubes. At t = 0, 0.75
μL 100% DMSO and appropriately diluted samples of 2,4-dinitrophenol,
nisin, or 921.191 Da dibromopeptide (in 100% DMSO) were added to cell
aliquots. The tubes were capped and incubated at 37 °C in a roller. After
20 min, 3 μL cells were added to 0.75 μL stain mix containing 30 μg/mL FM
4–64, 2.5 μM Sytox Green, and 1 μg/mL DAPI prepared in 1× T base and
placed on a 10% LB 1.0% agarose pad containing 0.375 μg/mL FM 4–64
and 0.025 μg/mL DAPI.
De Novo Assembly for OT59 and O4M1A. Paired-end Illumina reads generated
on Illumina GAIIx were used for the de novo assembly of the genomes of
O4M1A and OT59. The quality-trimmed reads were assembled de novo using
the assembler Velvet (v1.2.07) with hash-length parameter of 25 (PubMed
Identifier: 18349386). This process resulted in an assembly of 5.4 Mb for
O4M1A comprised of 5,793 contigs with an N50 of 1.8 kb. The OT59 genome
was assembled into 1,484 contigs corresponding to 5.26 Mb with an N50 of
17.5 kb. Similar to earlier de novo assembly approaches (PMID: 20544019),
the assembled genome was annotated using the RAST server (PMID:
18261238) with default parameters, which resulted in 4,231 predicted cod-
ing sequences in O4M1A and 4,530 predicted coding sequences in OT59.
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